Achieving Maximum Results:
Putting Combination Therapy For HCV Into Practice
Presented during the annual meetings of the:
AASLD, AGA, ASGE, and SSAT
in Orlando, Florida on May 16, 1999
Introduction: Evolution of Therapy for Chronic Hepatitis C Eugene R. Schiff, MD  | 
Interferon/Ribavirin Combination Therapy in Treatment-Naive Patients  | 
Interferon/Ribavirin Combination Therapy in Relapsers  | 
Managing HCV in Nonresponders to Interferon Including Patients With Normal ALT Levels Bruce R. Bacon, MD  | 
Cost-Effectiveness of Treatment for Hepatitis C John B. Wong, MD  | 
Conclusion: Putting Theory Into Practice Willis C. Maddrey, MD  | 

